These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7369 related articles for article (PubMed ID: 1668532)

  • 1. Human melanoma targeting with alpha-MSH-melphalan conjugate.
    Ghanem GE; Libert A; Arnould R; Vercammen A; Lejeune F
    Melanoma Res; 1991; 1(2):105-14. PubMed ID: 1668532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line.
    Morandini R; Süli-Vargha H; Libert A; Loir B; Botyánszki J; Medzihradszky K; Ghanem G
    Int J Cancer; 1994 Jan; 56(1):129-33. PubMed ID: 8262669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
    Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
    Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempts to use alpha-melanotropin-containing melphalan in melanoma patients.
    Lejeune FJ; Ghanem GE
    Ann N Y Acad Sci; 1993 May; 680():391-400. PubMed ID: 8390159
    [No Abstract]   [Full Text] [Related]  

  • 6. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
    Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
    J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate.
    Shafir I; Schmidt-Sole J; Shai E; Salomon Y
    Melanoma Res; 1993 Jun; 3(3):157-68. PubMed ID: 8400853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.
    Giblin MF; Wang N; Hoffman TJ; Jurisson SS; Quinn TP
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):12814-8. PubMed ID: 9788997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-MSH receptor autoradiography on mouse and human melanoma tissue sections and biopsies.
    Bagutti C; Oestreicher M; Siegrist W; Oberholzer M; Eberle AN
    J Recept Signal Transduct Res; 1995; 15(1-4):427-42. PubMed ID: 8903955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ.
    Tatro JB; Entwistle ML; Lester BR; Reichlin S
    Cancer Res; 1990 Feb; 50(4):1237-42. PubMed ID: 2153454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.
    Kameyama K; Vieira WD; Tsukamoto K; Law LW; Hearing VJ
    Int J Cancer; 1990 Jun; 45(6):1151-8. PubMed ID: 2161802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous regulation of the MSH receptor in melanoma cells.
    Siegrist W; Eberle AN
    J Recept Res; 1993; 13(1-4):263-81. PubMed ID: 8383755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
    Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
    Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma.
    Lunec J; Pieron C; Thody AJ
    Melanoma Res; 1992 May; 2(1):5-12. PubMed ID: 1322755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
    Wong W; Minchin RF
    Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents.
    Tatro JB; Reichlin S
    Endocrinology; 1987 Nov; 121(5):1900-7. PubMed ID: 2822378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.
    Solca FF; Chluba-de Tapia J; Iwata K; Eberle AN
    FEBS Lett; 1993 May; 322(2):177-80. PubMed ID: 8482388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 369.